✦ LIBER ✦

750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR

✍ Scribed by S.S. Good; X.-R. Pan-Zhou; M. Larsson; S. Luo; J.R. Selden; H. Rashidzadeh; S. Bhadresa; M. Camire; C. Parsy; D. Surleraux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

344 PRECLINICAL PROFILES OF IDX136 AND I

✍ L.B. Lallos; J.P. Bilello; M.A. Soubasakos; J. Gillum; M. La Colla; M. Liuzzi; J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

323 PRECLINICAL PHARMACOKINETIC AND SAFE

✍ S.S. Good; C. Bu; M. Camire; B. Hernandez-Santiago; M. Larsson; H. Rashidzadeh; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

768 IN VITRO ANTIVIRAL ACTIVITY OF IDX32

✍ L.B. Lallos; J. Mccarville; B. Li; J.P. Bilello; M. Lacolla; J. Jakubik; M.A. So 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

IDX375, A Novel Allosteric HCV Polymeras

✍ C.B. Dousson; S.S. Good; M. La Colla; J. Bilello; M. Seifer; D.N. Standring; J.- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 328 KB

761 IDENTIFICATION AND PRECLINICAL PROFI

✍ F. McPhee 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

588 IN VITRO ANTIVIRAL ACTIVITY AND PHAR

✍ E. Cretton-Scott; C. Perigaud; S. Peyrottes; L. Licklider; M. Camire; M. Larsson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB